At Aurore Life Sciences, our commitment to excellence is embodied in our state-of-the-art manufacturing units. These facilities are the engines behind the precision and quality synonymous with our pharmaceutical products.
Location:Aurore Pharmaceutical Pvt. Ltd. (Former Mylan Unit-II), Phase IV, IDA, Jeedimetla, Hyderabad.
Capabilities:5 Manufacturing blocks, 15 Clean rooms, 1 Solvent Recovery block.
Facility:Spanning across a vast area, with a built-up space of 17,201 Sq. Mtrs, and a lush green belt of 5,652 Sq. Mtrs.
Location:Aurore Life Sciences Pvt Ltd (Greenfield Manufacturing Site - Additional Capacities) located at Kazhipally, Hyderabad.
Capabilities:3 Manufacturing blocks, 4 Clean rooms.
Facility:Encompasses a total area of 28,730 Sq. Mtrs.
Aurore's manufacturing units hold approvals from prestigious regulatory bodies such as the FDA, WHO, HPRA, TGA, and more. This regulatory pedigree ensures that clients can have unwavering confidence in the quality, safety, and compliance of the pharmaceutical products manufactured by Aurore.
Aurore's manufacturing units are equipped with cutting-edge technology and advanced equipment, enabling the precision and quality needed for pharmaceutical manufacturing. From high potent API manufacturing to greenfield sites with sustainable practices, Aurore offers diverse and state-of-the-art facilities to cater to various client needs.
Aurore has a strong presence in regulated markets across the globe, including Europe, USA, Canada, Israel, Brazil, Jordan, Japan, South Korea, and China. This global reach allows clients to tap into Aurore's extensive experience and regulatory approvals for expanding their pharmaceutical products to international markets.
Aurore demonstrates a commitment to environmental responsibility through features like effluent treatment plants with MEE and ZLD systems. Clients looking for partners with sustainable manufacturing practices will find Aurore's approach appealing.